Cellprp Ltd

Cellprp Ltd, based in Burgess Hill, UK, is a small, active company founded four years ago. With a single employee and £69,425 in assets, it's a solo venture led by a single director and owner, Dholakia Premal. The company operates in the specialists medical practice activities industries and is a regular importer of optical and medical tools and devices, with recent activity recorded just a few months ago.

The company’s website showcases a unique approach to platelet-rich plasma (PRP) therapy. It’s not just about selling products; it’s about promoting a “rediscovery” of PRP, emphasizing its versatility and potential for various clinical situations. The site details different PRP formulations and techniques, including a proprietary "GEL" separation method, and offers training courses and technical discussions. The focus is on medical-grade PRP, with a strong emphasis on quality, safety, and efficacy. The website also features a client portal, suggesting a direct-to-patient or specialized practitioner model.

Financially, Cellprp Ltd shows a mixed picture. Current assets increased by a substantial 77% to £69,000, a positive sign of improved liquidity. However, net assets also jumped significantly, up 220% to £18,000, driven by retained earnings, which suggests the company is profitable, but it’s also important to note that equity was very low to begin with. Cash bank on hand increased by 37% to £38,000, providing a buffer. Trade debtors rose by 23%, which could indicate expanding sales or potential collection issues. Creditors also increased by 49%, which could be a result of increased purchasing. The company’s small size (meeting two of three conditions for a small company) allows for agility, but the rising debt levels should be monitored. As a small company, it's exempt from an audit, so the figures are unaudited.

Registered in England/Wales under the registration number 13207389, with a registered address at RH15 8JN, England, Burgess Hill, 35 St. Peters Road.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.